FP6Индивидуална стипендия2008–2009

MODERN TB DETECTION · Multidrug-resistant and hypervirulent tuberculosis: integral approach to rapid detection and evolution

6РП — Действия „Мария Кюри“

Период
2008-02-07 → 2009-02-06
Финансиране от ЕС
103 304 €
Участници
1
Схема
IIF

Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.

Накратко на български

Генетичните маркери на туберкулозата се анализират, за да се създадат бързи методи за откриване на устойчиви на лекарства щамове, като например Пекинският генотип. Това помага за по-доброто проследяване на разпространението на болестта и контрола на епидемиологичната ситуация в Европа.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Final Activity Report Summary - MODERN TB DETECTION (Multidrug-resistant and hypervirulent tuberculosis: integral approach to rapid detection and evolution)

In this project, we: 1. searched for novel informative markers for molecular epidemiology of tuberculosis (TB) 2. Developed and optimised new tools for the detection of drug-resistant and virulent m. tuberculosis strains 3. modelled the co-evolution of m. tuberculosis with humans. The abovementioned objectives were basically achieved. The Beijing genotype is a globally spread lineage of m. tuberculosis which is often associated with drug resistance and increased virulence. Genome mapping identified two specific IS6110 insertions for the Beijing strain. This information was used for the development of the fast real-time polymerase chain reaction (PCR) method for the detection of Beijing strain, whose patent was under preparation by the time of the project completion. Based on extensive analysis of multiple molecular markers we proposed a cost-effective format of seven variable number tandem repeat (VNTR) loci for high-resolution epidemiological screening of these strains. Bayesian simulation showed that the Beijing B0 variant was a successful clone, rapidly and widely spread in Russia because of its specific pathogenic properties. M. tuberculosis population in Kaliningrad exclave of Russia was shown to share a joint pool of strains with the European part of Russia, while, at the same time, it exhibited a certain relatedness to the northern European neighbours, such as Poland and Germany. The high prevalence of the multidrug resistant (MDR) Beijing genotype strains was a major cause of the highly adverse epidemiological situation of MDR-TB in the Kaliningrad region of Russia that also had an impact on health situation in the European Union. Bulgaria, a new EU member, had a high rate of MDR-TB among new TB cases equal to 10.7 % with TB incidence being also high, at a rate of 41 per 100 000. Our analysis showed that emergence and spread of drug-resistant TB in Bulgaria were not associated with any particular genotypic variant but might be due to insufficient TB control measures. A reduced 5-locus VNTR set was recommended for the first-line screening of m. tuberculosis isolates in Bulgaria. Rifampicin (RIF) and Ofloxacin (OFL) are key components of anti-TB treatment and resistance to them serves as surrogate marker of MDR and extensively drug resistant TB (XDR-TB). We either developed or optimised macroarrays and real-time PCR methods to genotypically detect RIF and OFL resistance via the detection of rpoB and gyrA gene mutations in cultured strains and clinical samples. A new measure of genetic distance between geographic populations within a microbial species based on the observed difference in the frequencies of its subtypes was proposed. It was applied to phylogeographic analysis of m. Tuberculosis, while geographic distribution of VNTR-subtypes within Beijing genotype was interpreted in light of human historical and recent migrations. The comparative analysis revealed strong geographic specificities of the local clonal variants of M. tuberculosis. Large water masses were the most efficient and drastic generators of the genetic divergence between human populations. The same situation appeared also true for m. tuberculosis, whose general diversity pattern amazingly resembled that of its human host. At the same time, less expected affinities that were observed between distant populations of m. tuberculosis could reflect hidden patterns of human migrations or yet unknown epidemiological links between distant regions. Beijing genotype likely originated from north-central China, appearing more than 2 000 years ago. Its historic introduction to other world regions was driven by human movements either medieval, to Russia, or more recent, to South Africa since the 17th century and to Australia during the 19th century.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Multidrug-resistant (MDR) and hyper-virulent (HV) Mycobacterium tuberculosis (MTB) strains increasingly circulate worldwide and start to threat European and global health security. Rapid detection of these hazardous MTB variants presents the first step in fighting TB and is vital for both patient and community health. We propose a novel integral approach to tackle modern TB. We propose to develop a three-step strategy based on use of sensitive molecular techniques and including simultaneous (1) diagnosis of TB (2) detection of drug-resistant, and (3) hyper-virulent MTB strains.The obtained information will be used for timely prevention of TB including early diagnosis and adequate treatment of TB patients and prognosis of the eventual emergence of new hazardous strains in future. Understanding genetic basis of virulence in circulating strains will contribute to development of a new generation vaccine efficient against modern TB. Additionally, the project will further develop a novel basic concept proposed by th e Applicant about human/microbial co-evolution.The generated data with be compared with unique global databases at the Host laboratory in order:(1) to reconstruct global phylogeny of M. tuberculosis,(2) to better understand evolution and emergence of hyper-virulent M. tuberculosis,(3) to develop a quantitative approach to comparative analysis of human and microbial diversities and co-evolution that may be extended to other pathogens.A large MTB collection is already available at Host and Applicant's laboratories for this project that will bring together intellectual efforts and ideas of the Applicant with technical capacity and expertise of the Host. This project will be an excellent example of synergy in applied and basic research in Genomics for Health and Health Risks priorities of European Research Area that will be carried out in less-favoured region" of EU (Guadeloupe) thus promoting its development."

Оригинален текст от CORDIS (на английски).

Участници

  • INSTITUT PASTEUR DE GUADELOUPE · ABYMES, GUADELOUPEКоординаторНиво държаваФранция

Връзки

Данни: CORDIS, © Европейски съюз